Thermo Fisher Scientific Showcases Comprehensive Solutions for Biobanks at the Biobanking 2010
NewswireToday – /newswire/ – Philadelphia, PA, United States, 01/13/2010 – Thermo Fisher Scientific showcases comprehensive solutions for biobanks at the Biobanking 2010 conference (NYSE: TMO).
Thermo Fisher Scientific Inc., the world leader in serving science, will highlight its comprehensive portfolio of offerings for biobanks and biorepositories during the Biobanking 2010 conference. The company will exhibit across two booths in the sponsored booth area within the Earls Court Conference Centre in London, UK, February 4 – 5, 2010.
Thermo Fisher Scientific has the world’s largest breadth of offerings for biobanks, from biospecimen collection, processing, testing and storage to sample and data management. The end-to-end portfolio includes centrifuges, concentrators, freezers, robotics, 2D barcodes, microplate readers, mass spectrometers and comprehensive services that enable turn-key biobanking solutions. The company will showcase innovative services and software for biorepositories, including laboratory information management systems, laboratory equipment and storage and related services sold under its Thermo Scientific and Fisher BioServices brands.
In the sponsored booth area, the company will showcase its market-leading and award-winning Thermo Scientific Informatics software products. To maintain sample integrity and drive life science research and discovery, accurate, compliant and efficient management of biospecimens is critical.
Thermo Scientific Nautilus biospecimen tracking software is specifically designed to address the unique challenges of specimen collection, tracking, and storage. The software is designed for data capture, location management, chain-of-custody and handling assurance requirements. Furthermore, to address the unique needs of biobanks, Nautilus enables sample request management, consent management and instrument integration and automation. The result is that biobanks can significantly accelerate their development and value by providing users with better logistical and operational support, a more comprehensive understanding of the associated specimen information, tools that automate timely and error-prone processes and real-time information for faster, more informed decisions.
Fisher BioServices, the world leader in biological specimen management, will also exhibit in the sponsored booth area, demonstrating how it supports all sectors of the life science and clinical research industries. The Fisher BioServices exhibit will showcase comprehensive, turn-key solutions for all biobanking and biorepository needs including services for collection kits, transportation, processing, testing, storage and data management. The company’s biorepository services and software packages can be accessed remotely, allowing users to manage samples at any of Fisher BioServices’ global locations.
Fisher BioServices currently manages more than 170,000,000 samples worldwide. It was recently selected as the National Children’s Study (NCS) biological and environmental sample repository partner. The study examines the effects of environmental influences on the health and development of 100,000 children across the United States, following them from before birth until age 21. The contract was awarded by the National Institutes of Health in conjunction with a consortium that includes the Centers for Disease Control and Prevention and the Environmental Protection Agency. The company stores a variety of biological specimens, cell lines, tissues blood products and environmental samples. Fisher BioServices’ operations include facilities that are compliant with current good manufacturing, laboratory and tissue practices.
In addition to Thermo Scientific Nautilus biospecimen tracking software and Fisher BioServices’ solutions, Thermo Fisher Scientific’s end-to-end offering includes even greater capabilities, tools, and experience for building, equipping and managing biobanks. The comprehensive portfolio also includes centrifuges, concentrators, freezers, robotics, 2D barcode technology, microplate readers and mass spectrometers required by biobanking organizations for turn-key operations. The booth will feature new equipment that speeds processing and ensures sample security, including an automation-friendly instrument that de-caps a rack of screw top caps in seconds, new 2D barcode readers that can scan either a single tube or a single rack of tubes for instant sample identification and colored screw top caps that enable researchers to distinguish between different samples at a glance.
For more information about Thermo Scientific Informatics and Fisher BioServices turn-key solutions for biobanks, please visit the sponsored booth area at Biobanking 2010 in London.
Thermo Scientific and Fisher BioServices are part of Thermo Fisher Scientific, the world leader in serving science.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (www.thermo.com) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With 2008 revenues of $10.5 billion, we have approximately 34,000 employees and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike.
